Small Cell Lung Cancer
Small Cell Lung Cancer (SCLC) is a fast-growing type of lung cancer that is often associated with smoking. It can spread quickly and may cause symptoms like persistent cough, chest pain, and shortness of breath.
Small Cell Lung Cancer: BI 764532 Treatment Study
We are testing different doses of BI 764532 in patients with relapsed small cell lung cancer and other neuroendocrine cancers. The goal is to see if this treatment can help improve outcomes for those who have not responded to prior therapies.
What diseases are being studied?
Health conditions and diseases that the clinical trial is designed to study and treat.
Neuroendocrine Carcinoma
Neuroendocrine Carcinoma is a type of cancer that arises from neuroendocrine cells, which can be found throughout the body. Symptoms may vary widely depending on the tumor's location but can include abdominal pain, changes in bowel habits, and hormonal symptoms.
Large Cell Neuroendocrine Carcinoma
Large Cell Neuroendocrine Carcinoma is a rare and aggressive form of lung cancer that can be challenging to treat. It often presents with symptoms similar to small cell lung cancer, including cough and difficulty breathing.
Extra-pulmonary Neuroendocrine Carcinoma
Extra-pulmonary Neuroendocrine Carcinoma refers to neuroendocrine tumors that occur outside the lungs. Symptoms depend on the tumor's location and may include abdominal pain, hormonal changes, and other systemic effects.
Who can participate in the clinical trial?
These questions help us understand your situation so we can let the trial team know whether you might be a potential match. This is not a medical evaluation and is not part of the official screening, the study doctor will make the final decision..
- Are you at least 18 years old?
- Do you have a history of small cell lung cancer (SCLC), neuroendocrine carcinoma (epNEC), or large cell neuroendocrine carcinoma (LCNEC)?
- Are you currently pregnant or breastfeeding?
- Have you had major surgery in the past 28 days?
- Have you received any anti-cancer treatment in the last 4 weeks?
What experimental substances are being tested?
Experimental substances that are being investigated in this clinical trial. These are not yet approved for general use.
Bi 764532
Where is the clinical trial being conducted?
Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.
Loading map...
UZ Leuven
Respiratory Oncology
Heverlee, Belgium
Universitair Ziekenhuis Gent
Medical Oncology/ Drug Research Unit Ghent
Ledeberg, Belgium
Multiprofile Hospital For Active Treatment-Uni Hospital Ltd.
Oncology Department
Elin Pelin, Bulgaria
Sponsor: Boehringer Ingelheim International GmbH
Last updated: Nov 26, 2025
Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.